Introduction
============

The initiation and progression of fibrosis in the liver is tightly regulated by multiple pathways involving different hepatic and immune cell types (Bataller and Brenner [@b1]; Bataller et al. [@b2]). While macrophages and hepatic stellate cells (HSC) are considered the primary cell types mediating the inflammatory and profibrotic responses to liver injury (Ramachandran and Iredale [@b25],[@b26]), recent evidence indicates that hepatocytes also contribute to development of liver fibrosis (Copple et al. [@b7]). For example, apoptosis of hepatocytes is a critical factor for progression of liver fibrosis (Canbay et al. [@b3]). Phagocytosis of apoptotic hepatocytes by macrophages and HSCs activates these cells, resulting in the induction of proinflammatory/profibrogenic responses in the liver (Canbay et al. [@b3]). Further, hepatocyte-specific deletion of transcription factors, including Snail, a hypoxia-sensitive transcription factor (Rowe et al. [@b27]), and Smad 7, a regulator of transforming growth factor (TGF*β*) expression (Dooley et al. [@b10]), attenuate hepatic fibrosis, suggesting a role for hepatocyte-generated signals during activation of liver fibrosis. Taken together, studies such as these identify the hepatocyte as a critical player during the propagation of liver fibrosis.

Chronic alcohol consumption is a major risk factor for development of hepatic fibrosis (Bataller et al. [@b2]); however, the molecular mechanisms of alcohol-driven profibrogenic responses in the liver are still not well understood. Understanding the pathophysiological mechanisms for alcohol\'s contribution to the development of hepatic fibrosis will aid in the development of pharmacological interventions to both prevent and reverse alcoholic liver disease.

Recent studies have identified several pathways by which ethanol can enhance fibrotic responses. For example, ethanol-induced hepatocyte apoptosis is associated with increased fibrogenesis (Roychowdhury et al. [@b28]). Furthermore, ethanol metabolism by hepatocytes likely contributes to the development of hepatic fibrosis. The impact of the by-products of alcohol metabolism, acetaldehyde and reactive oxygen species (ROS), has been well studied. Acetaldehyde and ROS activate HSC and induce fibrosis via transcriptional upregulation of profibrotic mediators, including TGF*β*1, and thus increase extracellular matrix deposition (Mormone et al. [@b20]). However, the role for hypoxia, another consequence of ethanol metabolism (Wang et al. [@b35]), in ethanol-driven amplification of liver fibrosis has not been well studied and is the focus of the current investigation.

Cellular responses to hypoxia are primarily mediated via stabilization of the hypoxia-inducible factor 1*α* (HIF1*α*), an oxygen-sensing transcription factor (Nath and Szabo [@b21]). In response to hypoxia, HIF1*α* translocates from cytosol to the nucleus and forms dimers with HIF1*β*, a nuclear protein, and subsequently triggers transcription of a variety of genes, including the proinflammatory/fibrotic genes such as VEGF, iNOS, and COX-2 (Hirota et al. [@b14]). Hepatocyte-specific HIF1*α* is critical for a variety of liver pathologies including ischemia/reperfusion injury and drug-induced liver injury (Cursio et al. [@b8]; Wu et al. [@b37]; Nath and Szabo [@b21]). Stabilization of HIF1*α* in hepatocytes has also been implicated in the progression of liver fibrosis following bile duct ligation (BDL)-induced hepatic injury (Moon et al. [@b19]).

While it is clear that ethanol feeding induces localized hypoxia in the liver (Nishiyama et al. [@b22]; Chiang et al. [@b5]), the role of HIF1*α* in different stages of alcoholic liver disease is still controversial and not well understood. For example, HIF1*α* in hepatocytes has been reported to play both a protective (Nishiyama et al. [@b22]) and injurious (Nath and Szabo [@b21]) role during ethanol-induced steatosis and inflammation in mouse models of ad libitum ethanol feeding.

While these conflicting results on the role of HIF1*α* in the early stages of ethanol-induced liver injury demand more detailed studies (Mehal [@b17]), it is also critical to ascertain the role of HIF1*α* in the association between chronic ethanol consumption and hepatic fibrosis. Making use of a novel model in which moderate ethanol exposure exacerbates CCl~4~-induced hepatic fibrosis, we recently identified hepatocyte apoptosis as a critical contributor to ethanol\'s ability to amplify CCl~4~-induced fibrosis (Roychowdhury et al. [@b28]). One potential pathway of ethanol-induced apoptosis in the context of CCl~4~-induced fibrosis is via HIF1*α*-dependent pathways. HIF1*α*-induced apoptotic cell death is largely p53-dependent (Greijer and van der Wall [@b12]) and p53 is activated during progression of CCl~4~-induced liver fibrosis (Guo et al. [@b13]). Therefore, here we hypothesized that ethanol-driven hypoxia/HIF*α* activation induces p53 activation and apoptosis in hepatocytes, which subsequently leads to amplification of CCl~4~-induced profibrotic responses in the liver. Making use of hepatocyte-specific HIF1*α*-deficient mice, here we identified that moderate ethanol feeding in the context of CCl~4~ exposure activated hypoxia/HIF1*α*-mediated signaling in hepatocytes, leading to increased acetylation of p53 and hepatocyte apoptosis. These HIF1*α*-dependent responses in hepatocytes were critical for the exacerbation of CCl~4~-induced profibrotic responses following moderate ethanol exposure.

Materials and Methods
=====================

Materials
---------

Female C57BL/6J mice (10--12 weeks old) were purchased from Jackson Labs (Bar Harbor, Maine). Lieber-DeCarli high-fat ethanol and control diets were purchased from Dyets (Bethlehem, PA). Antibodies were from the following sources: antipimonidazole (PMD)-adduct (Hypoxyprobe Inc., Burlington, MA), HIF1*α* (Novus Biologicals, Littleton, CO), collagen 1 (Southern Biotech, Birmingham, AL), *α*-smooth muscle actin (*α*SMA, Sigma-Aldrich, St. Louis, MO), CYP2E1 (Abcam, Eugene, OR), HSC70 (Santa Cruz Biotechnology, Inc, Santa Cruz, CA), acetylated p53^K386^ (Abcam), PUMA (Millipore, Billerica, MA), and M30/anticytokeratin 18 fragments (Roche, Mannheim, Germany). Ly6c-FITC antibody was obtained from AbD Serotec (Raleigh, NC). Direct red was obtained from Sigma-Aldrich. Alexa Fluor 488 and 568-conjugated secondary antibodies were obtained from Invitrogen (Carlsbad, CA).

Generation of hepatocyte-specific HIF1*α*-deficient mice
--------------------------------------------------------

A homozygous colony of hepatocyte-specific HIF1*α*-deficient (ΔHepHIF1*α*^−/−^) mice on a C57BL/6 background (Ding et al. [@b9]) was established at the Cleveland Clinic by serial crossing of HIF1*α*^fl/fl^ (B6.129-*HIF1a*^*tm3Rsjo*^/J) mice with Alb-Cre (B6.Cg-Tg(Alb-cre)21Mgn/J) mice that express the Cre-recombinase under the albumin promoter. Both the parental strains were obtained from Jackson Labs. Mice were genotyped after each generation and checked for hepatocyte-specific conditional deletion of HIF1*α* allele. Genomic DNA was extracted by digesting mouse tail tissue in proteinase-K solution (1 mg/mL, Roche) at 50°C overnight. Hair and undigested debris were removed by centrifugation and DNA was collected via ethanol precipitation. Real-time polymerase chain reaction analysis was done using Bullseye EvaGreen SYBR qPCR reagent (MidSci, St. Louis, MO) on a Chromo4 Cycler (MJ Research/Bio-Rad, Hercules, CA) using primer sequences as follows: Hif1*α*, forward primer CGT GTG AGA AAA CTT CTG GAT G; reverse primer AAA AGT ATT GTG TTG GGG CAG T; cre, forward primer TGA TGG ACA TGT TCA GGG ATC; reverse primer CAG CCA CCA GCT TGC ATG A. PCR conditions were detailed as follows: 95°C for 5 min, 95°C for 30 sec, 58°C for 30 sec, 72°C for 30 sec followed by 35 cycles of 95°C for 30 sec, 72°C for 5 min, and 4°C on hold. PCR products were resolved on a 2% agarose gel with ethidium bromide; Hif1a primers yield three potential fragments, a 565-bp fragment for a WT animal, 565 and 615 bp fragments for a heterozygote, and 615-bp fragment for a KO animal. Cre primers yielded a 865-bp fragment. Primer concentration was used as 0.5 μmol/L per primer and dNTP concentration used was 0.2 mmol/L.

Mouse models of moderate ethanol and carbon tetrachloride
---------------------------------------------------------

In order to study the interaction between ethanol and CCl~4~-induced liver fibrosis, mice were subjected to chronic CCl~4~-treatment combined with moderate ethanol (11% of kcal) feeding. The concentration and duration of ethanol feeding used in this model does not induce expression of cytochrome P450 mono-oxygenase (CYP2E1), a key enzyme for ethanol metabolism, as well as bioactivation of CCl~4~ (Roychowdhury et al. [@b28]; Chiang et al. [@b5]) ([Fig. S2](#SD2){ref-type="supplementary-material"}). The combination of moderate ethanol with CCl~4~ results in an exacerbation of hepatic fibrosis, characterized by increased activation of HSC and accumulation of extracellular matrix (Roychowdhury et al. [@b28]; Chiang et al. [@b5]).

Female mice were housed in shoe-box cages (two animals/cage) with microisolator lids. Standard microisolator handling procedures were used throughout the study. Mice were randomized into ethanol-fed and pair-fed groups and then adapted to control liquid diet for 2 days. The ethanol-fed group was then allowed free access to an ethanol-containing diet with 1% (vol/vol) ethanol for 2 days, then 2% (vol/vol) ethanol for the remainder of the study. The 2% diet provided 11% of calories as ethanol. After 4 days of ethanol feeding, mice were injected with 0.25 *μ*L/g CCl~4~ (Sigma, St. Louis, MO, Cat. No. 270652), followed by 0.50 *μ*L/g CCl~4~ 3 days later and then administered 1 *μ*L/g body weight of CCl~4~ (intraperitoneally twice a week) using 100 *μ*L Hamilton syringes fitted with 26G 5/8 inch needles for 5 weeks. Mice continued on either the control or the ethanol diet (11% of calories) during the CCl~4~ exposure period.

Seventy-two hours after the last CCl~4~ injection, mice were anesthetized, blood samples taken into nonheparinized syringes from the posterior vena cava, and livers excised. Portions of each liver were then either fixed in formalin or frozen in optimal cutting temperature (OCT) compound (Sakura Finetek U.S.A., Inc., Torrance CA) for histology, frozen in RNAlater (Qiagen, Valencia, CA) or flash frozen in liquid nitrogen and stored at −80°C until further analysis. Blood was transferred to ethylenediamine-N,N,N\',N\'-tetraacetic acid (EDTA)-containing tubes for the isolation of plasma. Plasma was then stored at −80°C.

All procedures using animals were approved by the Cleveland Clinic Institutional Animal Care and Use Committee.

In order to confirm that each of the parental strains had a similar response to EtOH/CCl~4~ exposure, Sirius red staining was assessed as a measure of fibrosis. C57BL/6 mice as well as the parental HIF1*α*^fl/fl^ and Alb-cre mice exhibited comparable increases in ethanol-induced Sirius red staining following chronic CCl~4~ exposure (see [Fig. 4](#fig04){ref-type="fig"}). Therefore, C57BL/6 mice were used as controls for all other studies.

Detection of hypoxia
--------------------

After 4 days of ethanol feeding mice were injected with the hypoxia-sensing drug, PMD, 1 h before euthanasia (Chiang et al. [@b5]). Samples were collected as detailed above.

Western blot analysis
---------------------

Frozen liver tissue (0.5--1.0 g) was homogenized in lysis buffer (10 mL/g tissue) containing 50 mmol/L Tris-HCl, pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 mmol/L NaCl, 1 mmol/L EDTA with added protease inhibitors Complete™ (Roche Diagnostics, Mannheim, Germany), 17.5 *μ*g/mL aprotinin, 5 *μ*g/mL bestatin, 10 *μ*g/mL leupeptin, 1 mg/mL bacitracin, and 20 *μ*g/mL E64), and phosphatase inhibitors (1 mmol/L vanadate and 10 mmol/L Na pyrophosphate) using 15 strokes in a glass on glass homogenizer (loose pestle). After 15 min on ice, samples were centrifuged at 16,000*g* for 15 min to remove insoluble material followed by protein concentration measurement using the bicinchoninic acid (BCA) assay (Pritchard et al. [@b23]). Liver lysates were then normalized and prepared in Laemmli buffer and boiled for 5 min. Samples were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to membranes for western blotting. Membranes were incubated with rabbit anti-CYP2E1-antibody (Research Diagnostics, Inc., Flanders, NJ, 1:200 dilution) overnight at 4°C, then washed and incubated for 1 h in anti-rabbit secondary antibody (1:25000 dilution) coupled to horseradish peroxidase. Immunoreactive proteins were detected using enhanced chemiluminescence, images were collected, and signal intensities were quantified using Eastman Kodak Co. Image Station 4000R (Eastman Kodak Company, Rochester, NY).

CYP2E1 activity assay
---------------------

Activity of CYP2E1 was determined by measuring *p*-nitrophenol hydroxylation in whole liver extract as described earlier (Wu and Cederbaum [@b36]).

Isolation of RNA and quantitative real-time polymerase chain reaction
---------------------------------------------------------------------

Total RNA was isolated and reverse transcribed followed by amplification using qRT-PCR. The relative amount of target mRNA was determined using the comparative threshold (Ct) method by normalizing target mRNA Ct values to those of 18S (Mandal et al. [@b16]). The reaction mix (25 *μ*L) contained: cDNA, Applied Biosystems SYBR green kit (Life Technologies, Carlsbad, CA) and primers at final concentrations of 200 μmol/L. RT-PCR was performed in the Mx3000P cycler (Agilent, Santa Clara, CA): 95°C for 10 min, 40 cycles of 15 sec at 95°C, 30 sec at 60°C, 30 sec at 72°C followed by 1 min at 95°C, 30 sec at 55°C, and 30 sec at 95°C. The relative amount of target mRNA was estimated using the Ct method by normalizing target mRNA Ct values to those of 18S (Mandal et al. [@b16]). ΔCt values were used for the statistical analysis of RT-PCR data.

Immunohistochemistry
--------------------

Formalin-fixed paraffin-embedded liver sections were deparaffinized and stained for PMD adduct, Sirius red, *α*-SMA and cytokeratin-18 fragments/M30 staining. Frozen liver sections were used for staining HIF1*α*, collagen 1, and Ly6c (Roychowdhury et al. [@b28]). All images presented in the results are representative of at least three images per liver and four mice per experimental condition.

Statistical analysis
--------------------

All values presented represent means ± standard error of mean, with *n* = 3--6 experimental points. Data were analyzed by analysis of variance using the general linear models procedure (SAS, Carey, NC). Data were log transformed if needed to obtain a normal distribution. Follow-up comparisons were made by least square means testing. Student\'s *t*-test was used for comparing values obtained from two groups (used only for Fig. [1](#fig01){ref-type="fig"}).

![Moderate ethanol feeding induced hypoxia and expression of HIF1*α* in mouse livers. (A, B) C57BL/6J wild-type mice were allowed free access to ethanol-containing diets with ethanol- (11% of kcal) or pair-fed controls. (A) Animals were injected with PMD 1 h before euthanasia. Paraffin-embedded liver sections were deparaffinized and stained for PMD-adducts. Images were acquired using 10× objective. (B) Frozen liver sections from pair- or ethanol-fed (11% of kcal) mice were stained for HIF1*α*. Images were acquired using 20× objective. \**P* \< 0.05 pair-fed compared to ethanol-fed mice.](prp20002-e00061-f1){#fig01}

Results
=======

Moderate ethanol feeding induced hypoxia in mouse liver
-------------------------------------------------------

Chronic ethanol feeding induces hypoxia in mouse liver (Nishiyama et al. [@b22]; Chiang et al. [@b5]). Using immunohistochemical staining, accumulation of hypoxia-sensing PMD adducts was detected in mouse liver as early as 4 days after moderate ethanol feeding (4d, 11%, Fig. [1](#fig01){ref-type="fig"}A). PMD adducts were primarily visualized in hepatocytes around the central veins (Fig. [1](#fig01){ref-type="fig"}A). Moderate ethanol feeding for 4 days also increased HIF1*α* protein expression in mouse liver (4d, 11%, Fig. [1](#fig01){ref-type="fig"}B), primarily localized around the central veins. HIF1*α* protein accumulation was not detected in livers of ΔHepHIF1*α*^−/−^ mice ([Fig. S1](#SD1){ref-type="supplementary-material"}A).

Moderate ethanol feeding combined with CCl~4~ exposure also increased HIF1*α* protein accumulation in liver of wild-type, but not ΔHepHIF1*α*^−/−^ mice ([Fig. S1](#SD1){ref-type="supplementary-material"}B). HIF1*α* protein accumulated in both the nucleus and cytosol and did not exhibit any zonal distribution.

Hepatocyte HIF1*α* deficiency reduced the numbers of apoptotic hepatocytes in mouse liver
-----------------------------------------------------------------------------------------

Hepatocyte apoptosis is an important contributor to the progression of hepatic fibrosis (Canbay et al. [@b3]; Roychowdhury et al. [@b28]). Hypoxia induces apoptosis in a variety of cell types, including hepatocytes. Caspase-mediated cytokeratin-18 fragmentation, detected by M30 staining, is a specific indicator of hepatocyte apoptosis. While higher doses of ethanol induces hepatocytes apoptosis, moderate ethanol feeding alone does not result in hepatocyte apoptosis (Cohen et al. [@b6]). In contrast, CCl~4~ exposure resulted in a modest degree of hepatocyte apoptosis, as detected by M30-positive hepatocytes. This response was exacerbated by concomitant ethanol feeding (Fig. [2](#fig02){ref-type="fig"}A and B). While hepatocyte-specific deletion of HIF1*α* had no effect on M30-positive hepatocytes in pair-fed mice, the absence of HIF1*α* in hepatocytes ameliorated the exacerbation of M30-positive hepatocytes in ethanol-fed mice (Fig. [2](#fig02){ref-type="fig"}A and B).

![Exacerbation of CCl~4~-induced hepatocyte apoptosis by ethanol was attenuated in livers of ΔHepHIF1*α*^−/−^ mice. C57BL/6 wild-type (WT) and ΔHepHIF1*α*^−/−^ mice were allowed free access to diets with ethanol- (11% of kcal) or pair-fed controls for 4 days followed by CCl~4~ injections, as described earlier. (A) Paraffin-embedded liver sections were deparaffinized and stained for M30/CK18 fragments, a marker for hepatocyte apoptosis. Images were acquired using a 20× objective. (B) Total numbers of M30^+^ cells were counted. Values with different alphabetical superscripts were significantly different from each other, *P* \< 0.05 (*n* = 4--6).](prp20002-e00061-f2){#fig02}

CYP2E1 expression, assessed by Western blot and enzymatic activity ([Fig. S2](#SD2){ref-type="supplementary-material"}), the concentration of alanine aminotransferase (ALT) in the plasma, and triglycerides in the liver were not affected by diet or genotype ([Table S1](#SD3){ref-type="supplementary-material"}).

Deficiency of HIF1*α* in hepatocytes reduced acetyl-p53^K386^ and PUMA expression in hepatocytes
------------------------------------------------------------------------------------------------

In response to hypoxia, HIF1*α* induces apoptosis in a p53-dependent manner (Sermeus and Michiels [@b29]). p53 activity is regulated via both transcriptional and posttranslational mechanisms. In particular, acetylation of p53 is essential for its activation and DNA-binding activity (Tang et al. [@b33]). Under the conditions of our study, neither CCl~4~ exposure nor ethanol feeding affected expression of p53 mRNA in the liver (data not shown). In contrast, the immunoreactive quantity of acetylated p53 (Ac-p53^K386^) was increased in response to CCl~4~ exposure (Fig. [3](#fig03){ref-type="fig"}A). Further, concomitant ethanol feeding increased the numbers of Ac-p53^K386^-stained cells (Fig. [3](#fig03){ref-type="fig"}A, inset). Costaining with Ac-p53^K386^ and collagen 1 revealed that while a major population of Ac-p53^K386^-positive cells were localized in close proximity of the fibrotic septa, some of the Ac-p53^K386^-positive cells were also visualized farther from the collagen fibers (Fig. [3](#fig03){ref-type="fig"}B). Deletion of HIF1*α* in hepatocytes reduced the numbers of Ac-p53^K386^-positive cells following ethanol/CCl~4~ exposure (Fig. [3](#fig03){ref-type="fig"}A).

![Exacerbation of CCl~4~-induced p53 acetylation and PUMA expression by ethanol were attenuated in livers of ΔHepHIF1*α*^−/−^ mice. C57BL/6 wild-type (WT) and ΔHepHIF1*α*^−/−^ mice were allowed free access to diets with ethanol- (11% of kcal) or pair-fed controls for 4 days followed by CCl~4~ injections, as described earlier. (A) Ac-p53^/K386^, (B) Ac-p53^/K386^ (green) and collagen 1 (red) costaining, or (C) PUMA. Images were acquired using a 40× objective. PUMA (green) was costained with the nuclear stain DAPI (blue). (D) Total number of PUMA^+^ cells was counted. Values with different alphabetical superscripts were significantly different from each other, *P* \< 0.05 (*n* = 4--6).](prp20002-e00061-f3){#fig03}

PUMA, a p53-transcription-dependent effector molecule, is critical for p53-driven proapoptotic activities (Tang et al. [@b33]). PUMA expression was detected in both hepatocytes and nonparenchymal cells (NPCs) in livers of CCl~4~-exposed mice, with higher numbers observed after ethanol feeding (Fig. [3](#fig03){ref-type="fig"}B). Hepatocyte-specific HIF1*α*-deficiency reduced the numbers of PUMA-positive cells following ethanol/CCl~4~ exposure (Fig. [3](#fig03){ref-type="fig"}C). However, the number of PUMA-positive cells following CCl~4~ exposure in pair-fed mice was not different between livers of ΔHepHIF1*α*^−/−^ compared to wild-type mice (Fig. [3](#fig03){ref-type="fig"}D).

Hepatocyte-specific deletion of HIF1*α* attenuated CCl~4~-induced fibrosis in mouse liver
-----------------------------------------------------------------------------------------

Apoptosis is critical for progression of fibrosis in mouse liver. Since apoptosis of hepatocytes following moderate ethanol/CCl~4~ exposure was HIF1*α*-dependent, it would be expected to contribute in the exacerbation of fibrosis by ethanol. Moderate ethanol feeding (11% of kcal) during CCl~4~ exposure increased liver fibrosis in C57BL/6 mice, resulting in enhanced bridging of Sirius red staining, compared to CCl~4~-treated pair-fed mice (Fig. [4](#fig04){ref-type="fig"}A and B). Like C57BL/6 mice, the parental HIF1*α*^fl/fl^ and Alb-cre mice also exhibited ethanol-driven increases in Sirius red staining following chronic CCl~4~ exposure (Fig. [4](#fig04){ref-type="fig"}A and B).

![Ethanol-induced exacerbation of CCl~4~-induced Sirius red staining was reduced in livers of ΔHepHIF1*α*^−/−^ mice. C57BL/6, HIF1*α*^fl/fl^, Alb-cre, and ΔHepHIF1*α*^−/−^ mice were allowed free access to diets with ethanol- (11% of kcal) or pair-fed controls for 4 days followed by CCl~4~ injections, as described in Materials and Methods section. (A) Paraffin-embedded liver sections were deparaffinized and stained for Sirius red staining. Images are acquired using 20× objective. (B) Areas positive for Sirius red were quantified using Image Pro-Plus software and analyzed. Values with different alphabetical superscripts were significantly different from each other, *P* \< 0.05 (*n* = 4--6).](prp20002-e00061-f4){#fig04}

If hepatocyte-HIF1*α* contributes to ethanol-induced exacerbation of CCl~4~-mediated fibrosis, deficiency of HIF1*α* in hepatocytes should ameliorate this increase in fibrosis. Hepatocyte-specific deletion of HIF1*α* attenuated ethanol-induced exacerbation of CCl~4~-induced extracellular matrix (ECM) deposition, as detected by Sirius red staining (Fig. [4](#fig04){ref-type="fig"}A and B). However, in pair-fed control mice, CCl~4~-induced hepatic ECM deposition was not influenced by the expression of HIF1*α* in hepatocytes (Fig. [4](#fig04){ref-type="fig"}A and B).

Hepatic expression of collagen 1A1 mRNA (Fig. [5](#fig05){ref-type="fig"}C) and collagen 1 protein (Fig. [5](#fig05){ref-type="fig"}A and B) was also increased in the livers of C57BL/6 mice following combined exposure to ethanol and CCl~4~. Hepatocyte-specific HIF1*α*-deletion attenuated the increase in CCl~4~-induced collagen 1A1 mRNA and collagen 1 protein expression in ethanol-fed mice but not in pair-fed control mice (Fig. [5](#fig05){ref-type="fig"}A--C).

![Ethanol-induced exacerbation of CCl~4~-induced collagen 1 and smooth muscle actin expression were reduced in livers of ΔHepHIF1*α*^−/−^ mice. C57BL/6 wild-type and ΔHepHIF1*α*^−/−^ mice were allowed free access to diets with ethanol- (11% of kcal) or pair-fed controls for 4 days followed by CCl~4~ injections, as described in Materials and Methods section. (A) Frozen liver sections were used for collagen 1 staining. Images are acquired using 20× objective. (B) Areas positive for collagen 1 were quantified using Image Pro-Plus software and analyzed. (C) mRNA expression of Col1A1 was detected in mouse livers using qRT-PCR measurement. (D) Paraffin-embedded liver sections were deparaffinized and stained for *α*SMA staining. Images are acquired using 10× objective. (E) Areas positive for *α*SMA were quantified using Image Pro-Plus software and analyzed. (F) mRNA expression of *α*SMA was detected in mouse livers using qRT-PCR measurement. Values with different alphabetical superscripts were significantly different from each other, *P* \< 0.05 (*n* = 4--6).](prp20002-e00061-f5){#fig05}

Activation of HSC is a hallmark of liver fibrosis. In response to profibrogenic stimuli, quiescent HSCs are transformed to their activated phenotype and produce collagen fibers in the liver. If hepatocyte-derived HIF1*α* is involved in the activation of HSC during ethanol/CCl~4~ exposure, then the ΔHepHIF1*α*^−/−^ mice should be protected from this ethanol-induced amplification of HSC activation. Both mRNA (Fig. [5](#fig05){ref-type="fig"}F) and protein expression of *α*SMA (Fig. [5](#fig05){ref-type="fig"}D and E), a marker of HSC activation, increased in the liver of C57BL/6 mice following combined exposure to ethanol and CCl~4~ compared to mice pair-fed control diets during CCl~4~ treatment. Deletion of HIF1*α* specifically in hepatocytes attenuated this ethanol-induced increase in *α*SMA expression (Fig. [5](#fig05){ref-type="fig"}D--F).

HIF1*α* deficiency in hepatocytes reduced infiltration of monocytes/macrophages in mouse liver
----------------------------------------------------------------------------------------------

During early phases of liver fibrosis circulating innate immune cells, including Ly6c^+^ monocyte/macrophages, migrate to the site of injury to engulf the damaged cells. If attenuation of fibrosis following ethanol/CCl~4~-combined exposure in the liver of ΔHepHIF1*α*^−/−^ mice was associated with reduced monocyte/macrophages infiltration, recruitment of Ly6c^+^ cells to the liver should also be reduced in the livers of ΔHepHIF1*α*^−/−^ mice. Ly6c^+^ cells were increased following ethanol/CCl~4~-combined exposure compared to CCl~4~ in pair-fed control mice (Fig. [6](#fig06){ref-type="fig"}A and B). The majority of Ly6c^+^ cells were localized in close vicinity of collagen fibers (Fig. [6](#fig06){ref-type="fig"}C). This increase in Ly6c^+^ cells was reduced in CCl~4~-treated livers of ethanol-fed ΔHepHIF1*α*^−/−^ mice compared to the C57BL/6 mice (Fig. [6](#fig06){ref-type="fig"}A and B). The number of Ly6c^+^ cells was not different between ΔHepHIF1*α*^−/−^ and wild-type pair-fed control mice exposed to CCl~4~.

![Exacerbation of CCl~4~-induced Ly6c^+^ cell infiltration by ethanol were attenuated in livers of ΔHepHIF1*α*^−/−^ mice. C57BL/6 wild-type (WT) and ΔHepHIF1*α*^−/−^ mice were allowed free access to diets with ethanol- (11% of kcal) or pair-fed controls for 4 days followed by CCl~4~ injections, as described earlier. (A) Frozen liver sections were used for Ly6c staining. Images were acquired using a 20× objective. (B) Total numbers of Ly6c^+^ cells were counted. Values with different alphabetical superscripts were significantly different from each other, *P* \< 0.05 (*n* = 4--6). (C) Ly6C^+^ (green) and collagen 1 (red) were costained in frozen liver sections from C57BL/6 mice exposed to both ethanol and CCl~4~. White arrows indicate collagen 1-stained fibers and blue arrows indicate Ly6C^+^-stained cells.](prp20002-e00061-f6){#fig06}

Discussion
==========

Ethanol consumption induces hypoxia in the liver, particularly around the central veins (Nishiyama et al. [@b22]; Chiang et al. [@b5]). Hypoxia induces expression of multiple genes, regulated by the hypoxia-sensing transcription factors, HIF1*α* and HIF2*α*, in a cell-type-dependent manner (Nath and Szabo [@b21]). However, the contribution of hypoxia to development of ethanol-induced fibrosis has not yet been studied. Since chronic ethanol feeding, even at high ethanol concentrations, does not result in significant liver fibrosis in mice, we have recently adopted an alternative approach by exposing the mice to chronic CCl~4~ in presence of a moderate ethanol diet (Roychowdhury et al. [@b28]; Chiang et al. [@b5]). Using this model of ethanol-induced exacerbation of apoptosis and fibrosis, we have identified the importance of ethanol-induced hypoxia/HIF1*α* signaling in mediating the response, associated with increased p53 acetylation, PUMA expression, and hepatocyte apoptosis in livers from CCl~4~-exposed mice exposed to moderate ethanol. Importantly, hepatocyte-derived HIF1*α* also contributed to ethanol-induced amplification of profibrotic responses following chronic exposure to CCl~4~.

HIF1*α*, an important mediator of cellular and systemic responses to hypoxia, regulates the expression of a variety of genes associated with different hepato-pathologies. Moderate ethanol exposure increased HIF1*α* protein accumulation was detected in both nucleus and cytosol. Accumulation of HIF1*α* in the cytosol could be a consequence of either a temporary saturation of the nuclear transport machinery for HIF1*α* or a continued stabilization of HIF1*α* prior to nuclear transport. Here we find that hepatocyte HIF1*α* is an essential mediator of hepatocyte apoptosis in response to combined exposure to moderate ethanol and CCl~4~, but not in response to CCl~4~ alone. Although, moderate ethanol exposure alone is insufficient to trigger apoptosis in hepatocytes, our data indicate that ethanol-induced HIF1*α* accumulation acted to prime hepatocytes to a second injurious signal, for example, CCl~4~, contributing to an exacerbated proapoptotic response.

This specific contribution of hepatocyte HIF1*α* during moderate ethanol exposure is most likely a consequence of ethanol metabolism and the generation of a localized hypoxic environment. Metabolism of ethanol dysregulates energy metabolism, histone deacetylation, and apoptosis by impairing mitochondrial bioenergetics and NADH/NAD^+^ ratio in hepatocytes (Zakhari [@b38]). HIF1*α* can also impair cellular redox balance by increasing glucose metabolism and reducing mitochondrial function (Vengellur et al. [@b34]). Therefore, it is likely that ethanol-induced hypoxia/HIF1*α* expression sensitizes hepatocytes to a second hit, such as CCl~4~, leading to the increased proapoptotic environment in hepatocytes.

HIF1*α*-driven apoptosis is largely p53-dependent (Sermeus and Michiels [@b29]). While p53 expression is increased in some models of chronic ethanol feeding and CCl~4~ exposure (Guo et al. [@b13]), posttranslational modifications including acetylation, phosphorylation, methylation, sumoylation, and ubiquitination mediate activation of p53 transcriptional activity. Phosphorylation prevents the binding of p53 with Mdm2, a negative regulator of p53 activation, while acetylation of p53 is central to its DNA-binding activity and upregulation of the downstream mediators, such as PUMA, NOXA, and Bax, responsible for its proapoptotic activity (Tang et al. [@b33]). Recently, increased p53 acetylation has been implicated to hepatocyte apoptosis in a model of nonalcoholic fatty liver disease (Castro et al. [@b4]). Importantly, ethanol, both in vivo and in cultured cells, increases the acetylation of multiple proteins (Shepard and Tuma [@b30]). The most well-studied example is the ethanol-induced increase in histone acetylation that is mediated via decreased activity of sirtuin 1 (SIRT1), an NAD^+^-dependent protein deacetylase (Zakhari [@b38]). Increased NADH/NAD^+^ ratios generated during ethanol metabolism serve to decrease the activity of SIRT1 in hepatocytes (Zakhari [@b38]; Elliott and Jirousek [@b11]). Here, we used immunoreactive Ac-p53^K386^ as an indicator of p53 acetylation and detected increased Ac-p53^K386^ in both hepatocytes and NPCs near the fibrotic septa after CCl~4~ exposure. Concomitant ethanol feeding and CCl~4~ increased the numbers of Ac-p53^K386^-positive cells compared to pair-fed controls. Importantly, acetylation of p53 in response to ethanol and CCl~4~ was HIF1*α*-dependent. While we have not yet characterized the mechanism for increased acetylation of p53 under these conditions, it is known that acetylation of p53 is regulated via SIRT1-dependent deacetylation (Shepard and Tuma [@b30]), consistent with a likely interaction between ethanol and SIRT1-dependent deacetylation in the context of ethanol and CCl~4~-induced injury.

As further evidence for an increase in p53-dependent transcriptional activity in response to ethanol/CCl~4~, expression of PUMA, a downstream target of p53 activation (Qiu et al. [@b24]) was also increased in a HIF1*α*-dependent manner in hepatocytes and NPCs. The reduction in PUMA-positive hepatocytes in livers of ΔHepHIF1*α*^−/−^ mice is consistent with protection of hepatocytes from apoptosis in these mice.

Phagocytosis of dying hepatocytes induces a variety of proinflammatory cytokines/chemokines resulting in infiltration of monocytes and macrophages in the liver. Under the combined insult of moderate ethanol and CCl~4~, there was an increased recruitment of Ly6c^+^ cell populations compared to mice treated with only CCl~4~. Deficiency of HIF1*α* in hepatocytes reduced the numbers of hepatic Ly6c^+^ cells following combined exposure to ethanol and CCl~4~. These data suggest that hepatocyte-derived HIF1*α* contributes to increased hepatic infiltration of the proinflammatory/fibrotic populations of monocytes and macrophages following ethanol feeding, which in turn can modulate profibrotic responses following exposure to CCl~4~. Reduced numbers of Ly6c^+^ could be the result of altered chemokine release from HIF1*α*-deficient hepatocytes and/or a indirect result of decreased HSC activation and fibrosis. The exact mechanistic interaction between HIF1*α* in hepatocytes and the recruitment of Ly6c^+^ cells from the circulation will require further investigation.

HIF1*α* regulates the expression of a variety of genes associated with different hepato-pathologies, including SREBP (Nishiyama et al. [@b22]), a critical mediator of ethanol-induced hepatic steatosis, as well as VEGF and iNOS, key genes for progression of liver fibrosis and angiogenesis (Keith et al. [@b15]). In response to hypoxia, hepatocytes also release a variety of profibrotic molecules including PDGF-A, PDGF-B, and plasminogen activator inhibitor (PAI-1) in a HIF1*α*-dependent manner (Copple et al. [@b7]). Because ethanol metabolism results in a localized hypoxic environment within the liver, we hypothesized that HIF1*α* in hepatocytes is critical for the amplification of fibrosis by even moderate concentrations of ethanol. Indeed, we find that ΔHepHIF1*α*-deficient mice are protected from the exacerbation of CCl~4~-induced fibrosis by moderate ethanol.

Interestingly, deficiency of hepatocyte-HIF1*α* did not reduce the profibrotic parameters in pair-fed mice exposed to CCl~4~ alone, further indicating that hypoxia due to ethanol metabolism may be a unique contributor to hepatic fibrosis in the context of CCl~4~. Induction of fibrosis in response to CCl~4~, a potent hepatotoxin, is initiated by hepato-cellular necrosis followed by a surge of hepatic inflammation. Moderate ethanol feeding has no direct impact on necrotic injury of hepatocytes by CCl~4~, as indicated by ALT concentrations in the plasma (14, [Table S1](#SD3){ref-type="supplementary-material"}). In turn the data suggest that increased apoptosis of hepatocytes during ethanol exposure drives increased activation of HSC and subsequent ECM production.

It is interesting to note that, in contrast to the hepatocyte HIF1*α*-independent progression of fibrosis in control mice exposed to CCl~4~, liver fibrosis following BDL is reduced in livers of ΔHepHIF1*α*^−/−^ mice (Moon et al. [@b19]). The differential contribution of HIF1*α* in BDL- versus CCl~4~-driven fibrosis could be a consequence of pathophysiological differences between these two models. In contrast to the hepatocyte apoptosis and necrosis induced by CCl~4~, development of fibrosis following BDL proceeds with less severe hepatocyte injury, instead triggered by increased portal inflammation and proliferation of biliary epithelia and oval cells (Starkel and Leclercq [@b32]). Similarly, a differential role for PAI-1 in CCl~4~ compared to BDL-induced fibrosis has been observed; PAI-1 is profibrotic in CCl~4~-induced fibrosis, but antifibrotic during BDL-induced fibrosis (von Montfort et al. [@b18]).

In summary, we found that expression of HIF1*α* in hepatocytes following moderate ethanol exposure is critical for amplification of CCl~4~-induced proapoptotic, as well as profibrogenic, responses in mouse liver. Moreover, ethanol-induced fibrosis was associated with increased hepatic Ly6c^+^ cells, suggesting that HIF1*α* expression in hepatocytes also contributes to infiltration of monocyte/macrophage in the liver. Taken together, we have identified a critical link between activation of hepatocyte apoptosis, dependent on HIF1*α*/p53 axis, and development of hepatic fibrosis using a mouse model of ethanol-induced liver fibrosis. The association between ethanol and increased acetylation of p53 is of potential clinical relevance, as a variety of drugs to enhance deacetylase activity are currently under investigation (Elliott and Jirousek [@b11]; Shepard and Tuma [@b31]).
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BDL

:   bile duct ligation

HIF 1*α*

:   hypoxia-inducible factor 1*α*

HSC

:   hepatic stellate cells

NPC

:   nonparenchymal cells

OCT

:   optimal cutting temperature

PMD

:   pimonidazole

ROS

:   reactive oxygen species

TGF*β*

:   transforming growth factor

WT

:   wild type

*α*SMA

:   *α*-smooth muscle actin
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**Figure S1.** Ethanol-induced HIF1*α* expression in wild-type and ΔHepHIF1*α*^−/−^ mouse livers. C57BL/6J wild-type mice were allowed free access to diets with ethanol- (11% of kcal) or pair-fed controls for 4 days (A) followed by CCl~4~ injections twice a week for 5 weeks and maintained on ethanol- or control diets (B). Frozen liver sections were stained for HIF1*α*. Images were acquired using 40× objective (*n* = 3--6).

###### 

**Figure S2.** CYP2E1 expression in wild-type and ΔHepHIF1*α*^−/−^ mouse livers. C57BL/6 wild-type (WT) and ΔHepHIF1*α*^−/−^ mice were allowed free access to diets with ethanol (11% of kcal) or pair-fed controls for 4 days. Mice were then injected with CCl~4~ twice a week for 5 weeks and maintained on ethanol- or control diets. (A) CYP2E1 protein expression was measured in liver lysates using Western blot. Images are representative of at least 3--6 mice per group and values under the image are means and SEM. P, Pair-fed; E, EtOH-fed. (B) CYP2E1 activity was measured in liver homogenates. *n* = 3--6.
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**Table S1.** Body weight, food intake, plasma levels of liver enzyme and hepatic triglyceride after moderate ethanol feeding (32d, 11%) in presence of chronic CCl~4~ exposure.

###### 

**Table S2.** Gene-specific primer sequences for RT-PCR.
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